Law & Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law & Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Acacia Research Corp.
CombiMatrix launches influenza A detection technology
April 8th, 2006
Acacia Research Corp. (CBMX, ACTG) announced that its CombiMatrix group has launched its Influenza A detection and genotyping technology on the Custom Array 4X2K platform. This is another step in CombiMatrix's expansion of its product line and another step in CombiMatrix's goal to make Influenza A technology more available and affordable. CombiMatrix's 4X2K Influenza A Research microarray is a member of the catalog array product line and can detect and accurately type flu strains using a protocol that requires less than hours starts to finish, at a cost pretest much lower than with the earlier Custom Array 12K version. This microarray can identify...
Source: Law & Health Weekly (2006-04-08)
|
